Glucose-responsive enzymatic biomimetic nanodots for H2O2 self-supplied catalytic photothermal/chemodynamic anticancer therapy
- PMID: 37802309
- DOI: 10.1016/j.actbio.2023.10.001
Glucose-responsive enzymatic biomimetic nanodots for H2O2 self-supplied catalytic photothermal/chemodynamic anticancer therapy
Abstract
Photothermal therapy (PTT) combined with chemodynamic therapy (CDT) presents an appealing complementary anti-tumor strategy, wherein PTT accelerates the production of reactive oxygen species (ROS) in CDT and CDT eliminates residual tumor tissues that survive from PTT treatment. However, nanomaterials utilized in PTT/CDT are limited by non-specific damage to the entire organism. Herein, a glucose-responsive enzymatic Fe@HRP-ABTS/GOx nanodot is judiciously designed for tumor-specific PTT/CDT via a simple and clean protein-templated biomimetic mineralization synthesis. By oxidizing glucose in tumor cells, glucose oxidase (GOx) activates glucose-responsive tumor therapy and increases the concentration of H2O2 at the tumor site. More importantly, the self-supplied peroxide hydrogen (H2O2) can convert ABTS (2,2'-Hydrazine-bis(3-ethylbenzothiazoline-6-sulfonic acid) diamine salt) into oxidized ABTS (oxABTS) through horseradish peroxidase (HRP) catalysis for PTT and photoacoustic (PA) imaging. Furthermore, the Fe2+ arising from the reduction of Fe3+ by overexpressed GSH reacts with H2O2 to generate intensely reactive •OH through the Fenton reaction, concurrently depleting GSH and inducing efficient tumor CDT. The in vitro and in vivo experiments demonstrate superior cancer cell killing and tumor eradication effect of Fe@HRP-ABTS/GOx nanodot under near-infrared (NIR) laser irradiation. Collectively, the nanodots provide mutually reinforcing catalytic PTT/CDT anti-tumor strategies for treating liver cancer and potentially other malignancies. STATEMENT OF SIGNIFICANCE: Combinatorial antitumor therapy with nanomedicines presents great prospects for development. However, the limitation of non-specific damage to normal tissues hinders its further clinical application. In this work, we fabricated tumor-selective biomimetic Fe@HRP-ABTS/GOx nanodots for H2O2 self-supplied catalytic photothermal/chemodynamic therapy of tumors. The biomimetic synthesis strategy provides the nanodots with enzymatic activity in response to glucose to produce H2O2. The self-supplied H2O2 initiates photothermal therapy with oxidized ABTS and enhances chemodynamic therapy through simultaneous •OH generation and GSH depletion. Our work provides a new paradigm for developing tumor-selective catalytic nanomedicines and will guide further clinical translation of the enzymatic biomimetic synthesis strategy.
Keywords: Biomimetic synthesis; Chemodynamic therapy; Glucose responsiveness; Photoacoustic imaging; Photothermal therapy.
Copyright © 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
A multifunctional cascade bioreactor based on a layered double oxides composite hydrogel for synergetic tumor chemodynamic/starvation/photothermal therapy.Acta Biomater. 2022 Nov;153:494-504. doi: 10.1016/j.actbio.2022.09.024. Epub 2022 Sep 15. Acta Biomater. 2022. PMID: 36115653
-
A multifunctional cascade nanoreactor based on Fe-driven carbon nanozymes for synergistic photothermal/chemodynamic antibacterial therapy.Acta Biomater. 2023 Sep 15;168:580-592. doi: 10.1016/j.actbio.2023.07.006. Epub 2023 Jul 13. Acta Biomater. 2023. PMID: 37451659
-
Biomimetic nanoplatform with H2O2 homeostasis disruption and oxidative stress amplification for enhanced chemodynamic therapy.Acta Biomater. 2023 May;162:44-56. doi: 10.1016/j.actbio.2023.03.017. Epub 2023 Mar 18. Acta Biomater. 2023. PMID: 36934891
-
Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy.Mater Today Bio. 2022 Jan 4;13:100197. doi: 10.1016/j.mtbio.2021.100197. eCollection 2022 Jan. Mater Today Bio. 2022. PMID: 35036895 Free PMC article. Review.
-
Recent Advances on NIR-II Light-Enhanced Chemodynamic Therapy.Adv Healthc Mater. 2024 Apr;13(10):e2303451. doi: 10.1002/adhm.202303451. Epub 2023 Nov 27. Adv Healthc Mater. 2024. PMID: 37983596 Review.
Cited by
-
Designing Mesoporous Prussian Blue@zinc Phosphate Nanoparticles with Hierarchical Pores for Varisized Guest Delivery and Photothermally-Augmented Chemo-Starvation Therapy.Int J Nanomedicine. 2024 Jul 8;19:6829-6843. doi: 10.2147/IJN.S464186. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39005958 Free PMC article.
-
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects.Bioact Mater. 2025 Jun 13;52:393-421. doi: 10.1016/j.bioactmat.2025.06.003. eCollection 2025 Oct. Bioact Mater. 2025. PMID: 40585385 Free PMC article. Review.
-
Chlorogenic acid protects against myocardial ischemia-reperfusion injury in mice by inhibiting Lnc Neat1/NLRP3 inflammasome-mediated pyroptosis.Sci Rep. 2023 Oct 18;13(1):17803. doi: 10.1038/s41598-023-45017-2. Sci Rep. 2023. PMID: 37853132 Free PMC article.
-
A Copper-Based Photothermal-Responsive Nanoplatform Reprograms Tumor Immunogenicity via Self-Amplified Cuproptosis for Synergistic Cancer Therapy.Adv Sci (Weinh). 2025 May;12(19):e2500652. doi: 10.1002/advs.202500652. Epub 2025 Mar 24. Adv Sci (Weinh). 2025. PMID: 40125789 Free PMC article.
-
Anti-Tumor Strategies of Photothermal Therapy Combined with Other Therapies Using Nanoplatforms.Pharmaceutics. 2025 Feb 26;17(3):306. doi: 10.3390/pharmaceutics17030306. Pharmaceutics. 2025. PMID: 40142970 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous